Tag: medication

Rethinking long-term pain management This edition of Airing Pain has been supported with a grant from Kyowa Kirin donated for this purpose.  The opioid crisis reached its peak in the United States in 2017, where addiction and overprescription have led to 218,000 deaths from prescription overdoses between the years of 1999 and 2017. The ...

On Tuesday 7 July 2020, Airing Pain returns, with producer Paul Evans looking into opioid medication for chronic pain. Tune in as he speaks to two world-reknowned pain specialists, a GP and a chronic pain patient who maganged to reduce her medication, looking into the opioid addiction crisis, the rates ...

We are delighted to announce that our popular booklet on neuropathic pain has been revised and reprinted, thanks to an award from Foundation Scotland. The booklet, originally written by Dr John Lee, has been revised and updated by Dr Alan Fayaz, Consultant in Chronic Pain Medicine, Anaesthesia and ...

NICE guidance on cannabis-based medicines out for consultation The National Institute for Health and Care Excellence (NICE) has issued draft guidance for the use of cannabis-based medicines considering the evidence for their use in intractable nausea and vomiting; chronic pain; spasticity and epilepsy. It covers other related topics, ...

Half a century worth of research exists on neuropathic pain but what are the latest developments?  This edition of Airing Pain is facilitated by the neuropathic pain special interest group (NeuPSIG) of the International Association for the Study of Pain (IASP). With the previous edition of Airing Pain focusing ...

Find out about amitriptyline, how it works and the side effects that you might experience when first taking it.

How does the law affect people who use drugs to manage their pain? This edition is funded by Foundation Scotland On 1 April 2019 Pregabalin and Gabapentin, drugs recommended for the management of neuropathic pain, were re-classified as class C controlled substances. Medicinal Cannabis: Is it safe? Does it work ...

How does the law affect people who use drugs to manage their pain? To listen to this programme, please click here. Prefer a PDF?Download On 1 April 2019, Pregabalin and Gabapentin, drugs recommended for the management of neuropathic pain, were re-classified as class C controlled substances. Medicinal Cannabis: Is it safe? Does ...

Cannabis and Chronic Pain The journal Pain recently published an important study on the use of cannabis, and medicines based on cannabis (cannabinoids), for chronic pain conditions (chronic pain in cancer patients was specifically excluded). Researchers were from institutes in Sydney, Brisbane and London specialising in substance abuse ...

How cancer survivors can experience post-operative pain, and confronting the national issue of post-cancer treatment This edition is funded by The Agnes Hunter Trust. An ever-increasing cancer survivor rate means chronic pain associated with the condition and its treatment is growing. In the UK alone, cancer survivor rates have ...

A study published by the Journal of the American Medical Association finds that treatment with opioids was not superior to treatment with non-opioid medications in patients with chronic back pain, hip or knee osteoarthritis pain. You can find the full study here: http://ow.ly/veOf30iO8ms ...

Public Health England is launching a review into "growing problem" of prescription drug addiction. The review, which will take a year, will cover: sedatives and anti-anxiety drugs known as benzodiazepines and z-drugs (zolpidem and zopiclone)painkillers called opioids, pregabalin and gabapentin (the latter two are also used to treat epilepsy)antidepressants Article ...